VAMP5
Vesicle-associated membrane protein 5
Also known as: VAMP5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95183
- Gene
- VAMP5
- Ensembl
- ENSG00000168899
- Chromosome
- 2
- Canonical length
- 116 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Plasma membrane
OverviewNCBI Gene
Synaptobrevins/VAMPs, syntaxins, and the 25-kD synaptosomal-associated protein are the main components of a protein complex involved in the docking and/or fusion of vesicles and cell membranes. The VAMP5 gene is a member of the vesicle-associated membrane protein (VAMP)/synaptobrevin family and the SNARE superfamily. This VAMP family member may participate in vesicle trafficking events that are associated with myogenesis. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
116 residues, UniProt reviewed canonical sequence.
>O95183|VAMP5
1 MAGIELERCQ QQANEVTEIM RNNFGKVLER GVKLAELQQR SDQLLDMSST FNKTTQNLAQ
61 KKCWENIRYR ICVGLVVVGV LLIILIVLLV VFLPQSSDSS SAPRTQDAGI ASGPGNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against VAMP5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 204 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 204 nTPM
- tongue: 186 nTPM
- lung: 136 nTPM
- adipose tissue: 134 nTPM
- breast: 121 nTPM
- adrenal gland: 120 nTPM
Single-cell type
- kupffer cells: 465 nCPM
- melanocytes: 304 nCPM
- vascular endothelial cells: 291 nCPM
- decidual stromal cells: 246 nCPM
- hepatocytes: 232 nCPM
- lymphatic endothelial cells: 183 nCPM
Immune cell
- intermediate monocyte: 505 nTPM
- non-classical monocyte: 427 nTPM
- total PBMC: 283 nTPM
- T-reg: 250 nTPM
- classical monocyte: 223 nTPM
- gdT-cell: 181 nTPM
Brain region
- medulla oblongata: 47 nTPM
- thalamus: 45 nTPM
- hypothalamus: 41 nTPM
- spinal cord: 36 nTPM
- basal ganglia: 36 nTPM
- pons: 35 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.73
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.08
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- Golgi to plasma membrane protein transport
- muscle organ development
- skeletal muscle tissue development
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Synaptobrevin-like
- v-SNARE, coiled-coil homology domain
- Synaptobrevin
- Vesicle-associated membrane protein 5
- VAMP5, SNARE motif
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of VAMP5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads VAMP5 as an antibody target. Whether an autoantibody or antibody against VAMP5 could matter depends on whether native VAMP5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
VAMP5 is annotated at the cell surface, where native VAMP5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label VAMP5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...